Adopting a new software helps local company to diagnose cancer quicker and cheaper
A*STAR helps local companies to make good use of new technologies and open up new markets through its GET-Up scheme launched in 2003. A*STAR figures showed on 30 November that a total of 687 A*STAR researchers were lent to 387 SMEs for joint research works.
A*STAR's subsidiary, ETPL, is responsible for the commercialisation and licensing of technologies to the companies. It also helps researchers to better understand the market and develop technologies close to the industrial needs. For instance, JN Medsys, a local biotech company set up six years ago, is the only Asian company specialising in digital Polymerase Chain Reaction (dPCR) technology, and its advanced image processing software comes from A*STAR. The software allows the use of dPCR technology to diagnose cancer quicker and cheaper than alternatives in the market. Some of the local users of this technology include A*STAR's Institute of Bioengineering and Nanotechnology (IBN) and Genome Institute of Singapore (GIS).
Chief Executive Officer of ETPL Mr Philip Lim was quoted that ETPL’s technology transfer programme not only benefits companies, but also allows researchers to gain a better understanding of market needs, which helps them to develop research that is closer to commercialisation needs. He also said that besides creating start-ups, A*STAR also helps increase the companies’ value proposition through upgrading technologies and products.
Information extracted from coverage on Lianhe Zaobao, 3 January 2017